Bartter syndrome screening: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
TayyabaAli (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{TAM}} | {{CMG}}{{AE}}{{TAM}} | ||
==Overview== | ==Overview== | ||
[[Genetic screening]] for [[Bartter syndrome]] | [[Genetic screening]] for [[Bartter syndrome]] mutated genes can be performed among individuals with unexplained [[hypertension]] and [[hypokalemia]]. | ||
==Screening== | ==Screening== | ||
Revision as of 12:48, 7 August 2020
Main article: Bartter syndrome
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Overview
Genetic screening for Bartter syndrome mutated genes can be performed among individuals with unexplained hypertension and hypokalemia.
Screening
- Genetic screening for Bartter syndrome pathogenic genes can be performed among individuals with unexplained hypertension and hypokalemia.[1]
- There is an insufficient evidence to recommend routine screening for Bartter syndrome.
References
- ↑ Bao M, Cai J, Yang X, Ma W (2019). "Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia". Clin Exp Hypertens. 41 (4): 381–388. doi:10.1080/10641963.2018.1489547. PMID 29953267.